Up to 5.4% of the total cells in GBM tumors is made up of MDSCs that mainly include lineage negative (CD14–CD15–), followed by granulocytic (CD14–CD15+) and monocytic (CD14+CD15–) subtypes (Raychaudhuri et al., 2015). Here, CD14 is linked to glioblastoma.